CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
CNBX Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 3.94% |
| November 30, 2023 | 55.93% |
| August 31, 2023 | 61.50% |
| May 31, 2023 | 87.11% |
| February 28, 2023 | |
| November 30, 2022 | |
| August 31, 2022 | |
| May 31, 2022 | |
| February 28, 2022 | |
| November 30, 2021 | |
| August 31, 2021 | |
| May 31, 2021 | |
| February 28, 2021 | |
| November 30, 2020 | |
| August 31, 2020 | 0.00% |
| May 31, 2020 | 0.00% |
| February 29, 2020 | 0.00% |
| Date | Value |
|---|---|
| November 30, 2019 | 0.00% |
| August 31, 2019 | 0.00% |
| May 31, 2019 | 0.00% |
| February 28, 2019 | 0.00% |
| November 30, 2018 | 0.00% |
| August 31, 2018 | 0.00% |
| May 31, 2018 | 0.00% |
| February 28, 2018 | -642.1% |
| November 30, 2017 | 0.00% |
| August 31, 2017 | -51.72% |
| May 31, 2017 | -18.75% |
| February 28, 2017 | 58.33% |
| November 30, 2016 | |
| August 31, 2016 | 0.00% |
| May 31, 2016 | 0.00% |
| February 29, 2016 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 88.57% |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 95.92% |
| Fulcrum Therapeutics, Inc. | -- |
| Definium Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -3.04K% |